| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.003 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |